MARKET

ISR

ISR

ISORAY
AMEX

Real-time Quotes | Nasdaq Last Sale

0.8885
-0.0043
-0.48%
Closed 16:00 01/29 EST
OPEN
0.9100
PREV CLOSE
0.8928
HIGH
0.9330
LOW
0.8796
VOLUME
521.03K
TURNOVER
--
52 WEEK HIGH
1.010
52 WEEK LOW
0.2875
MARKET CAP
59.30M
P/E (TTM)
-13.2730
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of ISR and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 3 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

ISR News

  • IsoRay files for $80M mixed shelf
  • seekingalpha.6d ago
  • One Thing To Remember About The IsoRay, Inc. (NYSEMKT:ISR) Share Price
  • Simply Wall St..01/14 14:11
  • IsoRay Likely Has Further To Rise
  • Seeking Alpha - Article.12/09/2019 18:07
  • If You Had Bought IsoRay (NYSEMKT:ISR) Stock Five Years Ago, You'd Be Sitting On A 63% Loss, Today
  • Simply Wall St..12/09/2019 17:06

More

Industry

Biotechnology & Medical Research
-0.30%
Pharmaceuticals & Medical Research
+0.09%

Hot Stocks

Name
Price
%Change

About ISR

IsoRay, Inc. is a medical technology company. The Company, through its subsidiary, IsoRay Medical, Inc., develops, manufactures and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases. The Company is engaged in the production and sales of Cesium-131 (Cs-131) brachytherapy seeds. Brachytherapy seeds are small devices containing a therapeutic dose of radiation used in an interstitial radiation procedure. The brachytherapy procedure places radioactive seeds as close as possible to (in or near) the cancerous tumor. The Cs-131 includes radioisotope in the treatment of all malignant tumors, such as prostate cancer, brain cancer, breast cancer, colorectal cancer, gynecological cancer, lung cancer, liver cancer, ocular melanoma and pancreatic cancer. The Company's Proxcelan Cesium-131 seed is classified as a Class II device.
More

Webull offers IsoRay, Inc. (ISR) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.